Summary
- Current Price
- As of today, TSHA price is $4.59, up +0.44% on
- Current Price All-Time High
- TSHA price is currently -86.24% below its historical high of $33.35 set on
- Market Cap
- TSHA current market cap is $1B, up +250.46% over the past 365 days
- PE Ratio
- TSHA PE ratio is unknown
- Revenue
- TSHA current annual revenue is $8.33M, down -46.07% year-over-year
- Next Earnings
- The next earnings release for TSHA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Taysha Gene Therapies, Inc. |
| Ticker | NASDAQ: TSHA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | tayshagtx.com |
| Employees | 73 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $4.59 | |
| Price, 1D Change | +0.44% | |
| $1B | ||
| - | ||
| - | ||
| 1.10 | ||
| $8M | ||
| Revenue, 1Y Change | -46.07% | |
| -$0.36 | ||
| EPS, 1Y Change | +62.84% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.36 | ||
| EPS Estimate | -$0.34 | |
| EPS Est. Change | +5.69% | |
| $8.33M | ||
| Revenue Estimate | $6.30M | |
| Revenue Est. Change | -24.39% | |
| Current Price | $4.59 | |
| Price Target | - | $11.00 |
| Price Tgt. Change | - | +139.65% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.47 | -$0.96 | +34.64% | |
| -$0.31 | -$0.36 | -15.16% | |
| -$0.34 | N/A | +5.69% | |
| -$0.42 | N/A | -17.17% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $14.48M | $15.45M | +6.71% | |
| $8.25M | $8.33M | +1.06% | |
| $6.30M | N/A | -24.39% | |
| $4.08M | N/A | -50.98% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $4.59 | |
| $3.88 | ||
| SMA 200 vs Price | -15.51% | |
| $4.83 | ||
| SMA 50 vs Price | +5.15% | |
| 1.10 | ||
| $0.25 | ||
| 47.27 | ||
| 35.02% | ||
| 98.30% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $8.33M | ||
| -$0.36 | ||
| $7.09M | ||
| 85.06% | ||
| -$86.62M | ||
| -1,039.49% | ||
| -$89.30M | ||
| -1,071.62% | ||
| -$85.38M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.89 | ||
| 5.41 | ||
| 5.42 | ||
| - | ||
| - | ||
| 0.13 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 199.25 | ||
| 5.74 | ||
| -10.19 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $71.53M | ||
| $139.04M | ||
| $276.41M | ||
| $142.13M | ||
| $204.88M | ||
| $26.23M | ||
| $63.95M | ||
| $1.88M | ||
| $3.59M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $97.63M | ||
| $93.71M | ||
| $1.25M | ||
| $0.00 | ||
| $1.25M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$81.23M | ||
| -$363.00K | ||
| $76.68M | ||
| $374.00K | ||
| -$81.60M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Needham | → | |
| Chardan Capital | → | |
| Wells Fargo | → | |
| Citizens | → | |
| Chardan Capital | → | |
| Raymond James | ||
| Needham | → | |
| Chardan Capital | → | |
| Needham | → | |
| Baird | → |
Analyst sentiment
Institutional ownership
Screeners with TSHA
FAQ
What is the ticker symbol for Taysha Gene Therapies, Inc.?
The ticker symbol for Taysha Gene Therapies, Inc. is NASDAQ:TSHA
Does Taysha Gene Therapies, Inc. pay dividends?
No, Taysha Gene Therapies, Inc. does not pay dividends
What sector is Taysha Gene Therapies, Inc. in?
Taysha Gene Therapies, Inc. is in the Healthcare sector
What industry is Taysha Gene Therapies, Inc. in?
Taysha Gene Therapies, Inc. is in the Biotechnology industry
What country is Taysha Gene Therapies, Inc. based in?
Taysha Gene Therapies, Inc. is headquartered in United States
When did Taysha Gene Therapies, Inc. go public?
Taysha Gene Therapies, Inc. initial public offering (IPO) was on September 24, 2020
Is Taysha Gene Therapies, Inc. in the S&P 500?
No, Taysha Gene Therapies, Inc. is not included in the S&P 500 index
Is Taysha Gene Therapies, Inc. in the NASDAQ 100?
No, Taysha Gene Therapies, Inc. is not included in the NASDAQ 100 index
Is Taysha Gene Therapies, Inc. in the Dow Jones?
No, Taysha Gene Therapies, Inc. is not included in the Dow Jones index
When was Taysha Gene Therapies, Inc. last earnings report?
Taysha Gene Therapies, Inc.'s most recent earnings report was on November 4, 2025
When does Taysha Gene Therapies, Inc. report earnings?
The next expected earnings date for Taysha Gene Therapies, Inc. is March 11, 2026
Data Sources & References
- TSHA Official Website www.tayshagtx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1806310/000119312525263506/0001193125-25-263506-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1806310/000095017025027348/0000950170-25-027348-index.htm
- TSHA Profile on Yahoo Finance finance.yahoo.com/quote/TSHA
- TSHA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tsha